Bone health and metabolic disorders are intricately linked, with conditions such as osteoporosis, osteomalacia, and Paget’s disease reflecting the profound impact of metabolic disruptions on skeletal integrity. Advances in understanding bone metabolism have revealed the critical role of hormones like parathyroid hormone, estrogen, and vitamin D in maintaining bone density and function. Imbalances in these hormones, coupled with lifestyle factors such as poor diet, physical inactivity, and smoking, can lead to weakened bones and increased fracture risk. Recent research has also highlighted the connection between metabolic disorders like diabetes and bone health, with studies showing that high blood sugar levels can impair bone regeneration and density. Targeted therapies, including bisphosphonates, monoclonal antibodies, and hormone replacement, are revolutionizing the management of these conditions, improving bone strength and reducing fracture risks. As the understanding of bone metabolism advances, more personalized treatment approaches are emerging, offering hope for better management of bone health and metabolic disorders.